宏观经济 | 动态跟踪 报告发布日期 2025 年 12 月 10 日 | 孙国翔 | 执业证书编号：S0860523080009 | | --- | --- | | | sunguoxiang@orientsec.com.cn | | | 021-63326320 | | 黄汝南 | 执业证书编号：S0860525120004 | | | huangrunan@orientsec.com.cn | | | 010-66210535 | | 孙金霞 | 执业证书编号：S0860515070001 | | | sunjinxia@orientsec.com.cn | | | 021-63326320 | | 王仲尧 | 执业证书编号：S0860518050001 | | | 香港证监会牌照：BQJ932 | | | wangzhongyao1@orientsec.com.cn | | | 021-63326320 | | 陈至奕 | 执业证书编号：S0860519090001 | | | 香港证监会牌照：BUK982 | | | chenzhiyi@orientsec.com.cn | | | 021-6332 ...

Investment Rating - The report maintains a "Positive" investment rating for the pharmaceutical and biotechnology industry, indicating an expected return that is stronger than the market benchmark by over 5% [5]. Core Insights - The National Medical Insurance Administration is strongly encouraging the high-quality development of innovative drugs, with clear policies supporting the payment side for innovative drugs. Domestic leading innovative drug companies are entering a commercial realization phase [3][7]. - The 2025 National Medical Insurance Drug List includes 127 products, with 114 successfully added, of which 50 are innovative drugs, marking a historical high. The overall negotiation success rate reached 90%, the highest in nearly seven years [7]. - The report highlights that the domestic innovative drug market is becoming increasingly concentrated, with leading companies like Heng Rui and Xin Da Biotech significantly benefiting from the new insurance policies [7]. Summary by Sections Investment Recommendations and Targets - Recommended stocks include Heng Rui Pharmaceutical (600276, Buy), Ke Lun Pharmaceutical (002422, Buy), Xin Li Tai (002294, Hold), Ao Sai Kang (002755, Buy), Jing Xin Pharmaceutical (002020, Buy), and others [3]. Market Dynamics - The report notes that the introduction of the commercial insurance directory marks the beginning of a "new golden decade" for Chinese innovative drugs, with a focus on high clinical efficacy and value innovation [7]. - The report emphasizes that the competition in the GLP-1 market remains clear, with the entry of new drugs not significantly altering the competitive landscape for existing treatments [7].

Core Insights - The report indicates an upward trend in the market with improved win rates, despite limited upward space, maintaining a mid-term oscillating pattern [3][9] - The report emphasizes the importance of mid-cap blue-chip stocks with solid fundamentals and clear industry positions, which are expected to attract incremental capital during the market's upward oscillation [4][9] - The brokerage sector is poised for growth due to favorable policy changes and internal transformations, leading to a clearer growth path for brokerage firms [5][9] - The military industry is highlighted for its dual demand from domestic and international markets, with significant investment opportunities anticipated as new equipment construction plans are set to be clarified [6][9] Market Strategy - The report notes a slight recovery in market sentiment following favorable policies for domestic insurance companies and a shift in the U.S. national security strategy, leading to a rebound in non-bank financials, metals, communications, and AI sectors [9] - It suggests that the "slow bull" market will continue, with mid-cap blue-chip stocks being the backbone of the market's upward movement [4][9] Industry Strategy - The brokerage sector is expected to benefit from a positive regulatory environment that encourages the differentiation of firms, promoting high-quality development and improved profitability [5][9] - The military sector is projected to see growth driven by new production capabilities and the expansion of military trade markets, particularly in unmanned systems and advanced equipment [6][9]

宏观经济 | 动态跟踪 12 月鹰派降息或在预期之内，未来货币政 策路径或在会议之外 研究结论 风险提示 美联储降息不及预期的风险。 美国经济陷入衰退的风险。 通胀超预期上行的风险。 模型测算存在偏差的风险。 报告发布日期 2025 年 12 月 09 日 有关分析师的申明，见本报告最后部分。其他重要信息披露见分析师申明之后部分，或请与您的投资代表联系。并请阅读本证券研究报告最后一页的免责申明。 | 王仲尧 | 执业证书编号：S0860518050001 | | --- | --- | | | 香港证监会牌照：BQJ932 | | | wangzhongyao1@orientsec.com.cn | | | 021-63326320 | | 吴泽青 | 执业证书编号：S0860524100001 | | | wuzeqing@orientsec.com.cn | | | 021-63326320 | | 孙金霞 | 执业证书编号：S0860515070001 | | | sunjinxia@orientsec.com.cn | | | 021-63326320 | | 戴思崴 | 执业证书编号：S086052 ...

Core Insights - The report indicates an upward trend in the market with improved win rates, despite limited upward space, maintaining a mid-term oscillating pattern [3][9] - The report emphasizes the importance of mid-cap blue-chip stocks with solid fundamentals and clear industry positions, which are expected to attract incremental capital during the market's upward oscillation [4][9] - The brokerage sector is expected to benefit from favorable policies and internal transformations, leading to a clearer growth path for performance [5][9] - The military industry is highlighted for its dual demand dynamics, with significant investment opportunities anticipated as new equipment construction plans are clarified [6][9] Market Strategy - The market has shown a slight recovery in risk appetite due to favorable domestic insurance investment policies and a shift in U.S. national security strategy, leading to a rebound in non-bank financials, metals, communications, and AI sectors [9] - The report suggests that the current market environment favors structural opportunities within advanced manufacturing, non-bank finance, technology, and cyclical sectors [9] Sector Strategy - The brokerage sector is undergoing a transformation driven by regulatory support for quality firms, which is expected to enhance leverage and profitability [5][9] - The report outlines a differentiated development pattern in the brokerage industry, focusing on strengthening leading firms while allowing smaller institutions to specialize [9] Thematic Strategy - The military sector is poised for growth with the upcoming "14th Five-Year Plan," emphasizing new production capabilities in unmanned systems and deep-sea technology [6][9] - The report identifies potential growth areas in military trade and civil applications, particularly as domestic power systems advance [6][9]

风险提示 宏观经济 | 动态跟踪 淡化总量，追求效能——理解 12 月政治局 研究结论 报告发布日期 2025 年 12 月 09 日 | 陈至奕 | 执业证书编号：S0860519090001 | | --- | --- | | | 香港证监会牌照：BUK982 | | | chenzhiyi@orientsec.com.cn | | | 021-63326320 | | 黄汝南 | 执业证书编号：S0860525120004 | | | huangrunan@orientsec.com.cn | | | 010-66210535 | | 孙金霞 | 执业证书编号：S0860515070001 | | | sunjinxia@orientsec.com.cn | | | 021-63326320 | | 孙国翔 | 执业证书编号：S0860523080009 | | | sunguoxiang@orientsec.com.cn | | | 021-63326320 | | 非美地区进口需求韧性绝非无源之水： | 2025-12-02 | | --- | --- | | 2026 年出口展望 | | | 难有 ...

Investment Rating - The industry investment rating is maintained as "Positive" [5] Core Insights - The report highlights a significant increase in exports to the United States, with rare earth prices expected to recover [2] - Supply constraints are strengthening demand, leading to a potential price recovery in the rare earth sector [8] - The report suggests focusing on leading companies with resource quotas and technological advantages in the rare earth industry [8] Summary by Sections Export Dynamics - In October 2025, China exported 5,473 tons of permanent magnets, a slight month-on-month decrease of 5.2% but a year-on-year increase of 15.8% [8] - Exports to the United States saw a substantial month-on-month increase of 56.1%, totaling 656 tons, with a year-on-year growth of 4.5% [8] - The cumulative export quantity for the first ten months of 2025 was 45,290.5 tons, reflecting a year-on-year decrease of 5.2% [8] Price Trends - The export value of rare earths in October was 1.92 billion RMB, a slight decrease of 4.7% month-on-month, with a per-ton price of 350,300 RMB [8] - The price of praseodymium-neodymium oxide fluctuated, reaching a high of 563,600 RMB per ton and dropping to a low of 501,300 RMB before recovering to 535,600 RMB by the end of October [8] Supply and Demand Outlook - Supply constraints are expected to persist due to slow growth in domestic rare earth mining quotas and geopolitical issues affecting imports [8] - Demand is anticipated to strengthen due to seasonal peaks in the electric vehicle and wind power sectors, alongside new production in humanoid robots [8] - The report predicts a sustained tight balance in supply and demand, with rare earth prices likely to rise steadily [8] Investment Recommendations - Short-term focus on global high-performance magnet leaders, particularly Jinli Permanent Magnet (300748, Buy) [8] - Long-term focus on leading companies in the rare earth industry, such as Northern Rare Earth (600111, Buy), benefiting from an optimized supply structure [8]

1. Report Industry Investment Rating - The report does not mention the industry investment rating [27][28][29] 2. Core View of the Report - Last week, convertible bonds rose slightly, and the valuation continued to decline as previously predicted, but then rebounded significantly after reaching the previous average. The anti - decline attribute of convertible bonds remained strong. The valuation rebound was mainly driven by equity - biased convertible bonds, while debt - biased ones were still weak. There is a clear valuation bottom, and the valuation top has loosened [6][9] - There is still strong support from the supply and demand sides, and the equity market is optimistic due to various policies. Although the current cost - performance of convertible bonds is low, there are still structural opportunities. Attention can be appropriately given to oversold bottom - position and defensive varieties. Be vigilant against the unexpected forced redemption risk of high - premium individual bonds. In December, short - term allocation can be made if there is a correction, and trading opportunities are greater than trend opportunities [6][9] - Last week, the equity market continued to rise driven by various positive factors. However, there was a strong wait - and - see sentiment at the end of the year. Overseas, the market was waiting for the result of the Fed's December interest - rate cut, and domestically, it was waiting for the tone of the Central Economic Work Conference. Institutional funds were under pressure from performance assessment and position adjustment, showing a cautious and optimistic attitude overall [6][9] 3. Summary According to the Directory 3.1 Convertible Bond Views: Valuation Rebounds after Decline, and Style Continues to Differentiate - Convertible bonds rose slightly last week. The valuation continued to decline as predicted, then rebounded significantly after reaching the previous average. The anti - decline attribute was strong. The rebound was mainly driven by equity - biased convertible bonds, and debt - biased ones were weak. The valuation bottom is clear, and the top has loosened [9] - There is strong support from supply and demand, and the equity market is optimistic due to policies. Despite the low cost - performance of convertible bonds, there are structural opportunities. Pay attention to oversold bottom - position and defensive varieties, guard against forced redemption risks of high - premium bonds. In December, short - term allocation can be considered for corrections, with more trading opportunities [9] - The equity market rose last week due to positive factors. But there was wait - and - see sentiment at year - end. Overseas awaited Fed's decision, and domestically awaited the Central Economic Work Conference. Institutional funds faced assessment and adjustment pressure, showing cautious optimism [9] 3.2 Convertible Bond Review: Convertible Bonds Rise Slightly, and Valuation Rebounds after Decline 3.2.1 Market Overall Performance: Most Equity Indexes Close Higher, and Trading Volume Continues to Decline - The equity market was weak first and then strong last week, continuing to rebound. Most indexes rose, such as the ChiNext Index (1.86%), the BeiZheng 50 (1.49%), and the CSI 300 (1.28%), while only the Science and Technology Innovation 50 fell slightly (0.08%) [13] - In terms of industries, non - ferrous metals, communication, and national defense and military industry led the gains, while media, real estate, and beauty care led the losses. The average daily trading volume decreased by 44.115 billion yuan to 1.69 trillion yuan [13] - The top ten rising convertible bonds last week were Yakelai Convertible Bond, Weidao Convertible Bond, etc. The more active ones in trading were Furong Convertible Bond, Dongshi Convertible Bond, etc [13] 3.2.2 Significant Trading Volume Contraction, and High - price, Medium - and High - rated Convertible Bonds Perform Well - Convertible bonds rose slightly last week. The valuation rebounded significantly after reaching the previous average, and the average daily trading volume dropped significantly to 50.91 billion yuan. The CSI Convertible Bond Index rose 0.08%, the parity center decreased 0.3% to 110.7 yuan, and the conversion premium rate center increased 0.3% to 20.6% [20] - In terms of style, high - price, medium - and high - rated convertible bonds performed well last week, while large - cap and double - low convertible bonds performed weakly [20]

国防军工行业 行业研究 | 行业周报 朱雀三号首飞成功入轨，卫星互联网产业 生态大会成功举办，火箭卫星有望共振 核心观点 投资建议与投资标的 国家/地区 中国 行业 国防军工行业 报告发布日期 2025 年 12 月 08 日 | 罗楠 | 执业证书编号：S0860518100001 | | --- | --- | | | luonan@orientsec.com.cn | | | 021-63326320 | | 冯函 | 执业证书编号：S0860520070002 | | | fenghan@orientsec.com.cn | | | 021-63326320 | | 鲍丙文 | 执业证书编号：S0860124070016 | | --- | --- | | | baobingwen@orientsec.com.cn | | | 021-63326320 | | 亚太局势不确定性加剧，我国装备建设或 | 2025-11-24 | | --- | --- | | 将提速，关注新质战斗力 | | | 无人僚机攻击-11 公开亮相，朱雀三号可回 | 2025-11-16 | | 收火箭即将首飞，关注新质战斗力 ...

固定收益 | 动态跟踪 资金难收紧，债市难大涨 固定收益市场周观察 研究结论 风险提示 政策变化超预期；货币政策变化超预期；经济基本面变化超预期；信用风险暴露超预 期；数据统计可能存在遗漏 | △ * = li | | --- | 报告发布日期 2025 年 12 月 08 日 | 齐晟 | 执业证书编号：S0860521120001 | | --- | --- | | | qisheng@orientsec.com.cn | | | 010-66210535 | | 杜林 | 执业证书编号：S0860522080004 | | | dulin@orientsec.com.cn | | | 010-66210535 | | 王静颖 | 执业证书编号：S0860523080003 | | | wangjingying@orientsec.com.cn | | | 021-63326320 | | 徐沛翔 | 执业证书编号：S0860525070003 | | | xupeixiang@orientsec.com.cn | | | 021-63326320 | | 债市难以复刻 2020 年末行情：固定收益市 | ...